ℹ️
🇬🇧
Search
Search for publications relevant for "Cisplatin: carboplatin"
Cisplatin: carboplatin
Publication
Class
Person
Publication
Programmes
publication
The Effect of Cisplatin, Carboplatin, Oxoplatin and Iproplatin on Antibody Response in Mice
1995 |
Faculty of Pharmacy in Hradec Králové
publication
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
2007 |
Third Faculty of Medicine
publication
Interactions of Platinum-Based Cytostatics with Metallothionein Revealed by Electrochemistry
2013 |
Faculty of Science, Second Faculty of Medicine
publication
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
2020 |
Second Faculty of Medicine
publication
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
2020 |
Second Faculty of Medicine
publication
Interactions of Platinum-Based Cytostatics with Metallothionein Revealed by Electrochemistry
2013 |
Publication without faculty affiliation
publication
Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors
2012 |
Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors
2012 |
Second Faculty of Medicine
publication
VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells
2017 |
Faculty of Science, Second Faculty of Medicine
publication
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
2019 |
Second Faculty of Medicine
publication
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
2017 |
Second Faculty of Medicine